Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Connected Government
- Consolidating Mission-critical Systems
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Data Privacy Imperative: Safeguarding Sensitive Data
- Eliminating the Pitfalls: Steps to Virtualization in Government
- Federal Executive Forum
- Federal Tech Talk
- Government Cloud Brokerage: Who, What, When, Where, Why?
- Government Mobility
- Mission-critical Apps in the Cloud
- Mobile Device Management
- The Modern Federal Threat Landscape
- The Path from Legacy Systems
- Understanding the Intersection of Customer Service and Security in the Cloud
Shows & Panels
Nike, AK Steel, Tiffany are big movers
Friday - 3/22/2013, 5:58pm EDT
NEW YORK (AP) -- Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
Nike Inc., up $5.93 at $59.53
The athletic shoe and clothing company said that its third-quarter net income rose 55 percent thanks to growth in North America.
AK Steel Holding Corp., down 16 cents at $3.31
The steel company projected a larger-than-expected first-quarter loss, saying a rise in demand hasn't materialized.
Tiffany & Co., up $1.32 at $69.23
The jewelry company said its fourth-quarter earnings edged up less than 1 percent, but its results still beat analysts' expectations.
Supervalu Inc., up 27 cents at $4.95
Shares of the supermarket operator continued to rise, a day after it completed a deal to sell five of its grocery chains.
Tibco Software Inc., down $2.18 at $20.99
The business software company reported its fiscal first-quarter profit fell by more than 50 percent on disappointing revenue.
Micron Technology Inc., up 97 cents at $10.04
The maker of memory chips posted a loss in its fiscal second quarter, but revenue beat Wall Street estimates.
Informatica Corp., down $1.71 at $34.15
A Nomura analyst downgraded the software company, saying that the risk versus the reward is not as compelling as it used to be.
Anacor Pharmaceuticals Inc., up $1.24 at $6.08
The drug developer reported strong data from a mid-stage study of a potential treatment for atopic dermatitis, a type of chronic rash.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.